RESEARCH PAPER
Estimation of cognitive and affective disorders occurrence in patients with Lyme borreliosis
 
More details
Hide details
1
Clinical Department of Infectious Diseases, Bytom, Medical University of Silesia, Katowice, Poland
2
Department of Infectious Diseases, Specialistic Hospital No 1, Bytom, Poland
3
Clinical Department of Psychiatry, Tarnowskie Góry, Medical University of Silesia, Katowice, Poland
CORRESPONDING AUTHOR
Barbara Oczko-Grzesik   

Clinical Department of Infectious Diseases, Bytom, Medical University of Silesia, Katowice, Poland
 
Ann Agric Environ Med. 2017;24(1):33–38
KEYWORDS
ABSTRACT
Introduction and objective:
Lyme borreliosis (LB) is a disease caused by the bacteria Borrelia burgdorferi. The most common symptoms are related to the skin, musculo-scelatal system, central and peripheral nervous system, rarely to the heart muscle and the eye, and may occur in the multistage course of the disease. LB may additionally be accompanied by psychopathological symptoms. The aim of the study is estimation of the cognitive and affective disorders occurence in patients with LB.

Material and Methods:
The study was carried out in the group of 121 patients (61 females, 60 males) aged 18–65; mean age 46 years. All patients were diagnosed with late-stage of LB: 46 patients (38%) with Lyme arthritis and 75 patients (62%) with neuroborreliosis. Evaluation of the cognitive and affective functioning of patients was performed on the basis of a standardized interview and test methods: the Mini-Mental State Examination (MMSE), Clock Drawing Test (CDT) and the Beck Depression Inventory (BDI).

Results:
Cognitive disorders occurred statistically significantly more often in patients with neuroborreliosis (14.7%) than in patients with Lyme arthritis (4.3%). A group of females with neuroborreliosis and a group of males with the same diagnosis demonstrated cognitive deficits significantly more often (23.3% and 8.9%, respectively), compared to groups of patients with Lyme arthritis (6.5% in females and no cognitive deficits in males). A significantly higher percentage of depressive disorders was also noted in the group of males and females with neuroborreliosis (50.7%), compared to the group of patients with Lyme arthritis (39.1%). The symptoms of depression were particularly frequent in the females with neuroborreliosis (60%). The severity of depression measured by BDI was mild or moderate in most cases. In the examined groups, more patients with neuroborreliosis (44%), both in females (36.7%) and males (48.9%), demonstrated anxiety disorders. The obtained results showed a higher frequency of affective disorders compared to cognitive deficits, both in patients with Lyme arthritis and neuroborreliosis.

Conclusions:
An increased frequency of depressive and neurotic disorders was observed in patients with LB, particularly in patients with neuroborreliosis. Neurotic disorders, mainly adaptive, were most common in males with LB, while depressive disorders were more frequent in females. An increased frequency of cognitive deficits was observed in patients with neuroborreliosis, particularly in females

 
REFERENCES (45)
1.
Paradowska-Stankiewicz I, Chrześcijańska I. Lyme borreliosis in Poland in 2011. Przegl Epidemiol. 2013; 67(2): 255–257.
 
2.
Stanek G, Fingerle V, Hunfeld K-P, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect. 2011; 17 (1): 69–79.
 
3.
Flisiak R, Pancewicz S. [Diagnostics and treatment for Lyme borreliosis. Recommendations of PTEiLChZ.]. www.pteilchz.org.pl/data/stand... (access: 2013.09.01) (in Polish).
 
4.
Rudnik-Szałaj I, Popławska R, Zajkowska J, Szulc A, Pancewicz SA, Gudel I. [Mental disorders in Lyme disease.] Pol Merk Lek. 2001; 11(65): 460–462 (in Polish).
 
5.
Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer E et al. A randomized, placebo-controlled trial of repeated iv antibiotic therapy for Lyme encephalopathy. Neurology. 2008; 70: 992–1003.
 
6.
Eikeland R, Ljostad U, Mygland A, Herlofson K, Lohaugen G.C. European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol. 2012; 19: 480–487.
 
7.
Bozzini S, Gambelli P, Boiocchi C, Schirinzi S, Falcone R, Buzzi P, et al. Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms. Int J Mol Med. 2009; 24(6): 813–818.
 
8.
Szczepańska-Sadowska E, Cudnoch-Jedrzejewska A, Ufnal M, Zera T. Brain and cardiovascular diseases: common neurogenic background of cardiovascular, metabolic and inflammatory diseases. Physiol Pharmacol. 2010; 61(5): 509–521.
 
9.
Talarowska M, Florkowski A, Gałecki P, Wysokiński A, Zboralski K. [Cognitive function and depression.] Psychiatr Pol. 2009; XLIII (1): 31–40 (in Polish).
 
10.
Rymaszewska J, Adamowski T, Pawłowski T, Kiejna A. [Prevalence of mental disorders – a review of major epidemiological research]. Post Psychiatr Neurol. 2005; 14(3): 195–200 (in Polish).
 
11.
Pawlak A, Krejca M, Janas-Kozik M, Krupka-Matuszczyk I, Rajewska J, Bochenek A. Ocena lęku i depresji w okresie okołooperacyjnym u pacjentów poddawanych rewaskularyzacji mięśnia sercowego. Psychiatr Pol. 20012; XLVI (1): 63–74 (in Polish).
 
12.
Jakubowska-Winecka A, Włodarczyk D. Psychologiczne aspekty choroby i chorowania. In: Jakubowska-Winecka A, Włodarczyk D. Psychologia w praktyce medycznej. Warszawa, PZWL, 2007. p.94–125 (in Polish).
 
13.
Corruble E, Guelfi JD. Pain complaints in depressed inpatients. Psychopathol. 2000; 33: 307–309.
 
14.
Jaracz J, Rybakowski J. [Depression and pain: novel clinical, neurobiological and psychopharmacological data]. Psychiatr Pol. 2005; XXXIX (5): 937–950 (in Polish).
 
15.
Borkowska A, Warwas I, Wiłkość M, Drożdż W. Neuropsychologiczna ocena dysfunkcji poznawczych w depresji po udarze mózgu. Psychiatria. 2007; 4(2): 39–44 (in Polish).
 
16.
Holtzheimer PE, Mayberg HS. Neuropsychiatryczne aspekty zaburzeń nastroju. In: Yudofsky SC, Hales RE. Neuropsychiatria. Wrocław, Elsevier Urban & Partner, 2010.p. 479–495.
 
17.
Bidzan L, Dutczak B, Grabowski J. Neurobiologiczne podłoże związków między emocjami a funkcjami poznawczymi. Psychoterapia. 2012; 3(162): 5–15 (in Polish).
 
18.
Stążka J, Szapietowska EM, Barańska E, Dudka P. Funkcjonowanie poznawcze osób z chorobą niedokrwienną serca leczonych kardiochirurgicznie – ocena przed i po zabiegu. Badania pilotażowe. Psychiatr Pol. 2012; XLVI(4): 539–552 (in Polish).
 
19.
Pużyński S, Wciórka J. Klasyfikacja zaburzeń psychicznych i zaburzeń zachowania w ICD-1. Badawcze kryteria diagnostyczne. Kraków-Warszawa, Vesalius, 1998 (in Polish).
 
20.
Gugała M, Łojek E, Lipczyńska-Łojkowska W, Bochyńska W, Sawicka B, Sienkiewicz-Jarosz H. [A review of neuropsychological methods for the assessment of mild cognitive impairment]. Post Psychiatr Neurol. 2007; 16(1): 81–85 (in Polish).
 
21.
Folstein M, Folstein S, Mchugh P. Mini-Mental State: a practical method for grading the cognitive state of patiens for the clinician. J Psych Res. 1975; 12: 189–198.
 
22.
Krzymiński S. Test Rysowania Zegara. Post Psych Neurol. 1995; 4(192): 21–30.
 
23.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4(6): 561–571.
 
24.
Zajkowska JM, Hermanowska-Szpakowicz T. Nowe aspekty patogenetyczne boreliozy z Lyme. Przegl Epidemiol. 2002; 56 (1): 57–67 (in Polish).
 
25.
Jarefors S, Janefjord CK, Forsberg P, Jenmalm C, Ekerfelt C. Decreased up-regulation of the interleukin-12Rβ2-chain and interferon-γ secretion and increased number of forkhead box P3-expressing cells in patients with a history of chronic Lyme borreliosis compared with asymptomatic Borrelia-exposed individuals. Clin Exp Immunol. 2006; 147: 18–27.
 
26.
Jacek E, Fallon BA, Chandra A, Crow MK, Wormser GP, Aleadini A. Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol. 2013; 255: 85–91.
 
27.
Zajkowska J, Drozdowski W. Neuroborelioza – trudności diagnostyczne. Neurol Dypl. 2013; 8(1): 6–15 (in Polish).
 
28.
Zajkowska JM, Kułakowska A, Tarasiuk J, Pancewicz SA, Drozdowski W. [Peripheral neuropathies in Lyme borreliosis]. Pol Merk Lek. 2010; XXIX(170): 115–118 (in Polish).
 
29.
Zajkowska J, Hermanowska-Szpakowicz T, Pancewicz S. [Lyme borreliosis – guidelines for effective treatment]. Zakażenia. 2007; 4: 33–38 (in Polish).
 
30.
DeLong AK, Blossom B, Maloney EL, Philips SE. Antibiotic retreatment of Lyme disease in patients with persistent symptoms: a biostatistical review of randomized, placebo-controlled, clinical trials. Contemp Clin Trials. 2012; 33:1132–1142.
 
31.
Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, et al. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013; 126: 665–669.
 
32.
Halperin JJ. Prolonged Lyme disease treatment. Neurology. 2008; 70: 986–987.
 
33.
Cameron DJ. Clinical trials validate the severity of persistent Lyme disease symptoms. Med Hypotheses. 2009; 72: 153–156.
 
34.
Halperin JJ, Baker P, Wormser GP. Common misconceptions about Lyme disease. Am J Med. 2013; article in press: http://dx.doi.org/10.1016/j.am....
 
35.
Hassett AL, Radvanski DC, Buyske S, Savage SV, Sigal LH. Psychiatric comorbidity and other psychological factors in patient with “Chronic Lyme Disease”. Am J Med. 2009; 122 (9): 843–850.
 
36.
Ogłodek E, Moś D, Araszkiewicz A. [Coexisting of borreliosis, depression and psoriasis]. Pol Merk Lek. 2010; XXVIII(163): 53–55 (in Polish).
 
37.
Legatowicz-Koprowska M, Gziut AI, Walczak E, Gil RJ, Wagner T. [Borreliosis – simultaneous Lyme carditis and psychiatric disorders – case report]. Pol Merk Lek. 2008; XXIV(143): 433–435 (in Polish).
 
38.
Helon B, Tłuczek TW, Buczyjan A, Adamczyk-Helon A, Wojnarowicz M. [Polymorhic mental disorders in the course of Lyme borreliosis – case study]. Psychiatr Pol. 2009; XLIII (3): 353–361 (in Polish).
 
39.
Stricker RB, Johnson L. Gender bias in chronic Lyme disease. J Womens Health. 2009; 18(10): 1717–1718.
 
40.
Gustaw K, Beltowska K, Studzińska MM. Neurological and psychological symptoms after the severe acute neuroborreliosis. Ann Agric Environ Med. 2001; 8(1): 91–94.
 
41.
Czupryna P, Kuśmierczyk J, Zajkowska JM, Ciemerych M, Kondrusik M, Ciemerych A, et al. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000–2005]. Pol Merk Lek. 2007; 23(134): 103–106 (in Polish).
 
42.
Rudnik I, Popławska r, Zajkowska J, Konarzewska B, Juchnowicz D, Pancewicz SA. [Mental problems in Lyme disease]. Pol Merk Lek. 2003; 15(86): 161–164 (in Polish).
 
43.
Blanc F, GEBLY. [Neurologic and psychiatric manifestations of Lyme disease]. Med Mal Infect. 2007; 37(7–8): 435–445 (in French).
 
44.
Westervelt HJ, McCaffrey RJ. Neuropsychological functioning in chronic Lyme disease. Neuropsychol Rev. 2002; 12(3): 153–177.
 
45.
Juchnowicz D, Rudnik I, Czernikiewicz A, Zajkowska J, Pancewicz SA.[Mental disorders in the course of Lyme borreliosis and tick borne encephalitis]. Przegl Epidemiol. 2002; 56 (Suppl. 1): 37–50 (in Polish).
 
eISSN:1898-2263
ISSN:1232-1966